ANVS

Annovis Bio, Inc. ANVS

NYSESmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$0

Quarter to Jun 30

Net income

$-14.82M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$20.22M total
Empery Asset Management, LP
$4.47MNew
MARSHALL WACE, LLP
$3.43M+55.1%
VANGUARD CAPITAL MANAGEMENT LLC
$3.06M+88.8%
TUDOR INVESTMENT CORP ET AL
$2.52MNew
RENAISSANCE TECHNOLOGIES LLC
$1.86M+188.3%
TWO SIGMA INVESTMENTS, LP
$1.08M-7.7%
GEODE CAPITAL MANAGEMENT, LLC
$528.1K+14.7%
BlackRock, Inc.
$464.7K+79.1%
CITADEL ADVISORS LLC
$453.2KNew
VANGUARD FIDUCIARY TRUST CO
$330.2K+34.4%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$273.1K-32.8%
Quadrature Capital Ltd
$169.0KNew
STATE STREET CORP
$144.6K0.0%
NORTHERN TRUST CORP
$126.6K-52.0%
FIRST NATIONAL TRUST CO
$111.6K+50.0%
Sherry Group, Inc.
$106.5K0.0%
GSA CAPITAL PARTNERS LLP
$93.0K+9.9%
Greenwich Wealth Management LLC
$90.0K+3.0%
Headlands Technologies LLC
$89.4KNew
Wescott Financial Advisory Group, LLC
$77.4K0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$70.1K0.0%
GILL CAPITAL PARTNERS, LLC
$69.1K+100.0%
WELLS FARGO & COMPANY/MN
$56.4K+111.8%
Dakota Wealth Management
$53.9K+11.5%
CWA Asset Management Group, LLC
$52.1K+64.7%
See all 61 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ANVS

Earnings Per Share

13fpro.ai/company/ANVS

Loading ratio trend…

ANVS insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Annovis Bio, Inc. (ANVS): stock profile, AI score and financials

Annovis Bio, Inc. (ANVS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ANVS is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of ANVS by reported 13-F value include Empery Asset Management, MARSHALL WACE, LLP, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ANVS trades on the NYSE exchange and files with the SEC under CIK 1477845. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ANVS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Annovis Bio, Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1477845 →